Randall Urban, MD
Vice President for Research &
Chief Research Officer

Dr. Randall Urban

Dr. Randall Urban leads a diverse research community in the bold mission to improve medical practice through progressive translational research endeavors. He has 145 peer-review publications, is the Principal Investigator of UTMB's Clinical and Translational Science Award, and has 3 major research interests funded by the NIH and private foundations. In addition to Vice President for Research and Chief Research Officer, Dr. Urban is Vice Dean for Clinical Research in the John Sealy School of Medicine, Professor of Internal Medicine, Director of the Institute for Translational Sciences, and Fellow, John P. McGovern Distinguished Chair in Oslerian Medicine.

Strategic Research Plan

The Strategic Research Plan, which is used by leadership to  develop a path forward through goals, objectives and tactics, has broad input. It includes six integrated health communities that bring together researchers, educators, clinicians and community members to use prevention and treatment to transform illness to health. Read more.

Research Funding
Awards Processed
Lab Space
See more research facts and figures online





Research grant awards target innovations in trauma care

Five University of Texas Medical Branch primary investigators received competitive grant awards totaling $1,722,433 from the Trauma Research and Combat Casualty Care Collaborative for six research projects.

Also known as TRC4, this initiative of the University of Texas System funds basic, clinical and translational research that can be rapidly translated to improve trauma care throughout the state of Texas, and ultimately nationally and internationally.

The 2024 UTMB projects receiving grant awards are:

  • Identification of Subtypes in Texas Burn Injuries: From Registries to Targeted Patient Care

    PI: Celeste Finnerty, PhD

  • Novel Strategies for Reducing Burn Scar Itch

    PI: Celeste Finnerty, PhD

  • Molecular Iodine for Advanced Complex Wound Management

    PI: Joseph Wenke, PhD

  • Targeting Polytrauma-induced Immunosuppression in a Novel Model of Invasive Fungal Disease

    PI: Alison Coady, PhD

  • Target Treatment of High Mobility Group Box 1 (HMGB1) Alleviates Skeletal Muscle Impairment in Burn and Hindlimb Unloaded Rats

    PI: Juquan Song, MD

  • Biorepository for Chronic Subdural Hematoma Treatment with Embolization Versus Surgery Study

    PI: Peter Kan, MD

“Trauma remains the leading cause of death for individuals up to the age of 45 years. Despite the increasing burden of traumatic injury on the US population, trauma care and research receive minimal funding compared to other causes of death around the world. Thanks to the very generous support and funding from the UT Board of Regents and the Texas Legislature, these grant awards will lay the foundation for improving care and reducing deaths caused from trauma,” said Dr. James Bynum, TRC4 Executive Director. “TRC4 is firmly committed to pioneering trauma care research and improving patient care in Texas and for our service members. These awards highlight the depth and expertise across the UT System institutions and ensure future opportunities for commercialization, device development, and early career scientist growth.”